Where is AVIcure located?

AVIcure is headquartered in Bethlehem, United States.

Is AVIcure a funded company?

AVIcure is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AVIcure rank among its competitors?

AVIcure ranks 31st amongst 29 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Amferia, which secured $4.11M in Dec, 2025.

Who are the top competitors of AVIcure?

AVIcure's top competitors include Aethlon Medical, Amferia and Cerus. Among them, Amferia secured the most recent funding round in December, 2025.

AVIcure - 2026 Company Profile & Competitors

AVIcure is a deadpooled company based in Bethlehem (United States), founded in 2013. It operates as an Ultraviolet blood irradiation for autoimmune diseases. The company has 29 active competitors, including 8 funded and 4 that have exited. Its top competitors include companies like Aethlon Medical, Amferia and Cerus.

Company Details

AVIcure develops medical devices using ultraviolet blood irradiation (UVBI) technology. The company offers ImmunoModulator, targetting a wide range of pathogens, designed to treat whole blood with ultraviolet photopheresis. It is an investigational device and has not been approved by the FDA for commercial distribution in the United States. The company also offers HemaSterilizer, which is a UVBI device, claimed to have a 99.99% success rate in the inactivation of pathogens. The third product offered by the company is the patented, FDA-approved Pulsed Radio Frequency Device (PRFD), which is used in the relief of chronic temporomandibular joint (TMJ) dysfunction and chronic anterior knee pain. The products have applications in autoimmune diseases, such as Gut Bacteria, Crohn’s Disease, diabetes, etc.

Website: avicure.com
Email ID: *****@avicure.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Bethlehem, United States

Stage

Deadpooled

Ranked

31^st among 33 competitors

Similar Companies

Aethlon Medical & 31 more

View AVIcure's full profile

AVIcure has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AVIcure include Aethlon Medical, Amferia and Cerus. Here is the list of Top 10 competitors of AVIcure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aethlon Medical 1999, San Diego (United States), Public	Immunotherapeutic device company combating cancer and life-threatening viral infections	-	NIH, HHS	55/100
2nd	Amferia 2018, Gothenburg (Sweden), Series B	Developer of an anti-infective technology	$7.56M	Almi Invest, Chalmers Ventures & 5 others	55/100
3rd	Cerus 1991, Concord (United States), Public	Provider of pathogen inactivation technology for blood center or hospital blood bank	-	MidCap Financial, Apollo Investment Corporation ... & 3 others	54/100
4th	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100
5th	Ondine Biomedical 1999, Vancouver (Canada), Public	Developer of anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections	$798K	Springboard Enterprises	49/100
6th	ARTCLINE 2007, Germany, Series A	Developer of immune cell-based extracorporeal therapies for intensive care medicine	$4.75M	-	46/100
7th	Z-App Kit 2007, Hafnarfjordur (Iceland), Unfunded	Developer of a amplifier and app for killing pathogenic microorganisms	-	-	45/100
8th	PATH EX 2016, Nashville (United States), Series A	Developing blood-cleansing device to remove pathogens from circulating blood	$5M	IAG Capital Partners, JLABS & 9 others	40/100
9th	Larada Sciences 2006, Salt Lake City (United States), Series A	Leading head lice treatment clinics offering fast, safe, effective solutions	$4.46M	Tech Coast Angels, ventureCapital.org & 1 others	36/100
10th	ToeFX 2016, Hamilton (Canada), Seed	Company discovering and developing treatment of toenail fungus (onychomycosis)	$30K	Accelerator Centre, The Forge	35/100
31st	AVIcure 2013, Bethlehem (United States), Deadpooled	Ultraviolet blood irradiation for autoimmune diseases	-	-	15/100